Antibody Drug Conjugates Market Research Report 2024
Report ID: AI313 | Number
of Pages: 240 | Publish Date: 2025-03-25
Antibody Drug Conjugates (ADC) are a type of focused medication formed to carry strong cytotoxic drugs, particularly to cancer cells. They contain three primary parts a monoclonal antibody, a Cytotoxic payload and the last one is a linker molecule. Antibody Drug Conjugates (ADC) are cancer therapies that combine the accuracy of monoclonal antibodies with the potent cytotoxicity of chemotherapy medications.